Measures · C22 in 2019 · Part C · HD2 Managing Chronic (Long Term) Conditions
Statin Therapy for Patients with Cardiovascular Disease
Chronic ConditionsHealth PlanMedication AdherenceSource: HEDIS
- What it measures
- This rating is based on the percent of plan members with heart disease who get the right type of cholesterol-lowering drugs. Health plans can help make sure their members are prescribed medications that are more effective for them.
- How it's calculated
- The percentage of males 21–75 years of age and females 40–75 years of age during the measurement year, who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) (denominator) and were dispensed at least one high or moderate-intensity statin medication during the measurement year (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2017 – 12/31/2017
- Better when
- Higher
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- —
- In improvement measure
- No
- Used in CAI
- No
- HEDIS label
- Statin Therapy for Patients with Cardiovascular Disease (SPC)
- Exclusions
Show
Exclude members who meet any of the following criteria: • Pregnancy (Pregnancy Value Set) during the measurement year or year prior to the measurement year. • In vitro fertilization (IVF Value Set) in the measurement year or year prior to the measurement year. • Dispensed at least one prescription for clomiphene (Table SPC-A) during the measurement year or the year prior to the measurement year. • ESRD (ESRD Value Set) during the measurement year or the year prior to the measurement year. • Cirrhosis (Cirrhosis Value Set) during the measurement year or the year prior to the measurement year. • Myalgia, myositis, myopathy, or rhabdomyolysis (Muscular Pain and Disease Value Set) during the measurement year. Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2017 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2017 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2018-2019) for contracts with 25% or more enrolled affected
From the 2019 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2019 star distribution
Not rated: Plan not required to report measure (130); Plan too new to be measured (66); No data available (53); Plan too small to be measured (39); Not enough data available (20); Benefit not offered by plan (2)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA | < 82 % | >= 82 % to < 86 % | >= 86 % to < 89 % | >= 89 % to < 93 % | >= 93 % |
| 2026 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 91 % | >= 91 % |
| 2025 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 92 % | >= 92 % |
| 2024 | MA | < 79 % | >= 79 % to < 84 % | >= 84 % to < 86 % | >= 86 % to < 90 % | >= 90 % |
| 2023 | MA | < 75 % | >= 75 % to < 81 % | >= 81 % to < 85 % | >= 85 % to < 89 % | >= 89 % |
| 2022 | MA | < 76 % | >= 76 % to < 81 % | >= 81 % to < 84 % | >= 84 % to < 89 % | >= 89 % |
| 2021 | MA | < 75% | >= 75% to < 79% | >= 79% to < 83% | >= 83% to < 87% | >= 87% |
| 2020 | MA | < 75% | ? 75% to < 79% | ? 79% to < 83% | ? 83% to < 87% | ? 87% |
| 2019 | MA | < 70% | ? 70% to < 76% | ? 76% to < 81% | ? 81% to < 85% | ? 85% |
Lowest-scoring contracts, 2019
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H2962 Ultimate Health Plans | Ultimate Healthcare Holdings, LLC | 22,713 | 56 | 1 | — | 25 | 0% |
| H2416 PrimeWest Health | PrimeWest Rural MN Health Care Access Initiative | 2,277 | 62 | 1 | — | 19 | 0% |
| H5433 CalOptima Health OneCare | Orange County Health Authority | 19,245 | 63 | 1 | — | 18 | 1% |
| H5190 Wellcare | Centene Corporation | 0 | 64 | 1 | — | 17 | 1% |
| H2029 Humana | Humana Inc. | 0 | 65 | 1 | — | 16 | 1% |
| H5594 Optimum HealthCare, Inc. | Elevance Health, Inc. | 81,062 | 65 | 1 | — | 16 | 1% |
| H6743 ATRIO Health Plans | ATRIO Health Plans | 21,042 | 67 | 1 | — | 14 | 2% |
| H3814 ATRIO Health Plans | ATRIO Health Plans | 1,997 | 69 | 1 | — | 12 | 2% |
| H5475 Wellcare | Centene Corporation | 18,951 | 69 | 1 | — | 12 | 2% |
| H5427 Freedom Health, Inc. | Elevance Health, Inc. | 94,740 | 69 | 1 | — | 12 | 2% |
| H0523 Aetna Medicare | CVS Health Corporation | 11,124 | 69 | 1 | — | 12 | 2% |
| H4213 Arkansas Blue Medicare | USAble Mutual Insurance Company | 2,258 | 70 | 2 | — | 11 | 3% |
| H5649 Central Health Medicare Plan | Molina Healthcare, Inc. | 30,678 | 70 | 2 | — | 11 | 3% |
| H1099 Health First Health Plans, Inc. | Health First Shared Services, Inc. | 37,197 | 70 | 2 | — | 11 | 3% |
| H5010 Asuris Northwest Health | Cambia Health Solutions, Inc. | — | 70 | 2 | — | 11 | 3% |
| H8604 The Health Plan | The Health Plan of West Virginia, Inc. | 7,183 | 71 | 2 | — | 10 | 4% |
| H4004 Medicare y Mucho Mas (MMM) | Elevance Health, Inc. | 101,304 | 71 | 2 | — | 10 | 4% |
| H0545 Inter Valley Health Plan | InterValley Health Plan | — | 71 | 2 | — | 10 | 4% |
| H4227 VISTA Health Plan Inc. | Independence Health Group, Inc. | 23,267 | 71 | 2 | — | 10 | 4% |
| H5425 SCAN Health Plan | SCAN Group | 410,778 | 71 | 2 | — | 10 | 4% |
| H7522 Medicare y Mucho Mas (MMM) | Elevance Health, Inc. | 0 | 71 | 2 | — | 10 | 4% |
| H1032 Wellcare | Centene Corporation | 47,845 | 72 | 2 | — | 9 | 6% |
| H3347 Elderplan | Elderplan, Inc. | 27,294 | 72 | 2 | — | 9 | 6% |
| H4922 AgeWell New York | ParkerCare New York, LLC | — | 72 | 2 | — | 9 | 6% |
| H0354 HealthSpring | Health Care Service Corporation | 75,493 | 72 | 2 | — | 9 | 6% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | C18 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2025 – 12/31/2025 | 1 | HEDIS |
| 2026 | C19 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2024 – 12/31/2024 | 1 | HEDIS |
| 2025 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2023 – 12/31/2023 | 1 | HEDIS |
| 2024 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2022 – 12/31/2022 | 1 | HEDIS |
| 2023 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2021 – 12/31/2021 | 1 | HEDIS |
| 2022 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2020 – 12/31/2020 | 1 | HEDIS |
| 2021 | C20 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2020 | C21 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2019 | C22 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2017 – 12/31/2017 | 1 | HEDIS |